Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oscar Solis

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Biorxiv : the Preprint Server for Biology|June 6, 2022
The SARS-CoV-2 spike protein binds and modulates estrogen receptorsOscar Solis, Andrea R Beccari, Daniela Iaconis, et al.
Science Advances|November 30, 2022
The SARS-CoV-2 spike protein binds and modulates estrogen receptorsOscar Solis, Andrea R Beccari, Daniela Iaconis, et al.
Nature|April 24, 2026
Author Correction: A µ-opioid receptor superagonist analgesic with minimal adverse effectsJuan L Gomez, Emilya N Ventriglia, Zachary J Frangos, et al.
Nature|April 1, 2026
A µ-opioid receptor superagonist analgesic with minimal adverse effectsJuan L Gomez, Emilya N Ventriglia, Zachary J Frangos, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Biorxiv : the Preprint Server for Biology|June 6, 2022
The SARS-CoV-2 spike protein binds and modulates estrogen receptorsOscar Solis, Andrea R Beccari, Daniela Iaconis, et al.
Science Advances|November 30, 2022
The SARS-CoV-2 spike protein binds and modulates estrogen receptorsOscar Solis, Andrea R Beccari, Daniela Iaconis, et al.
Nature|April 24, 2026
Author Correction: A µ-opioid receptor superagonist analgesic with minimal adverse effectsJuan L Gomez, Emilya N Ventriglia, Zachary J Frangos, et al.
Nature|April 1, 2026
A µ-opioid receptor superagonist analgesic with minimal adverse effectsJuan L Gomez, Emilya N Ventriglia, Zachary J Frangos, et al.
Pageof 3